...

Merus N.V.

Website bezoeken

Over de werkgever

Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have similar features as conventional monoclonal antibodies, such as long half-life and low immunogenicity.

Locatie werkgever

Vergelijkbare werkgevers

...
KU Leuven Leuven, België 104 vacatures
...
ETH Zürich Zürich, Zwitserland 69 vacatures
...
Ghent University Gent, België 68 vacatures
...
University of Luxembourg Luxemburg 53 vacatures
Meer werkgevers

Dit vind je misschien ook interessant

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) Leestijd: 4 min
...
The genetic detectives discovering who we really are University of Turku Leestijd: 5 min
...
Deciphering the Gut’s Clues to Our Health University of Turku Leestijd: 5 min
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) Leestijd: 5 min
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano Leestijd: 5 min
Meer stories